Merck & Co’s immuno-oncology drug Keytruda ... to overtake AbbVie and Eisai’s anti-inflammatory drug Humira (adalimumab), which is currently the world’s top-selling drug,” says Keshalini ...

Merck & Co/MSD’s three-drug antibiotic Recarbrio ... and Pfizer’s Amsparity – a biosimilar of AbbVie’s immunology blockbuster Humira (adalimumab).

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: February 14 at 7:59:47 PM EST Loading Chart for MRK ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

After hours: February 14 at 7:59:47 p.m. EST ...

Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain ...

After hours: February 14 at 7:14:20 p.m. EST ...

After hours: 7:14:20 pm GMT-5 ...